Cover Image

Real-world outcomes of initiating insulin glargine-based treatment versus premixed analog insulins among US patients with type 2 diabetes failing oral antidiabetic drugs

Onur Baser,1,2 Krishna Tangirala,3 Wenhui Wei,3 Lin Xie11STATinMED Research Inc, Ann Arbor, MI, 2Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 3Sanofi US, Inc., Bridgewater, NJ, USABackground: In patients with type 2 diabetes mellitus, basal-bolus strategies can improve tre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Baser O (Author), Tangirala K (Author), Wei W (Author), Xie L (Author)
Format:	Book
Published:	Dove Medical Press, 2013-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration
by: Samantha Walczuk, et al.
Published: (2024)

The economic prognosis of the new analog of insulin glargine usage in diabetes mellitus type 2
by: D. Yu. Belousov, et al.
Published: (2018)

Coventional insulin versus insulin analogs
by: Anil Gomber, et al.
Published: (2019)

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy
by: Jacques Lepercq, et al.
Published: (2012)

Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
by: I. N. Dyakov, et al.
Published: (2020)

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol
by: Sondra Davis, et al.
Published: (2017)

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II
by: Enrico Torre, et al.
Published: (2020)

Effect of insulin glargine on glycemic control in adolescents with type 1-diabetes
by: Hassan M. Mona, et al.
Published: (2015)

The pharmacoeconomic comparison of the fixed insulin glargine and lixisenatide combination with insulin degludec family in type 2 diabetes mellitus
by: I. N. Dyakov, et al.
Published: (2021)

Pharmacokinetic and pharmacodynamic similarity evaluation between an insulin glargine biosimilar product and Lantus® in healthy subjects: Pharmacokinetic parameters of both parent insulin glargine and M1 were used as endpoints
by: Yiya Wang, et al.
Published: (2022)

Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia
by: Yazed AlRuthia, et al.
Published: (2022)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
by: Shafie AA, et al.
Published: (2020)

Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2
by: S. V. Nedogoda, et al.
Published: (2020)

Electronic Health Records to Rapidly Assess Biosimilar Uptake: An Example Using Insulin Glargine in a Large U.S. Nursing Home Cohort
by: Kaleen N. Hayes, et al.
Published: (2022)

Pharmacoeconomic comparison of the second generation insulin analogs and insulins on their base
by: I. N. Dyakov, et al.
Published: (2021)

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
by: Kerry Mansell, et al.
Published: (2019)

Fitness versus Fatness and Insulin Resistance in U.S. Adolescents
by: Doyle M. Cummings, et al.
Published: (2010)

Cost of achieving HbA1c and weight loss treatment targets with IDegLira vs insulin glargine U100 plus insulin aspart in the USA
by: Billings LK, et al.
Published: (2019)

Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus
by: Ito H, et al.
Published: (2014)

Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
by: Shuo Zhang, et al.
Published: (2023)

Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
by: Kerry Mansell, et al.
Published: (2019)

Diurnal Variation of Real-Life Insulin Sensitivity Factor Among Children and Adolescents With Type 1 Diabetes Using Ultra-Long-Acting Basal Insulin Analogs
by: Ahmed M. Hegab
Published: (2022)

Health technology assessement of the fxed combination of insulin glargine 100 UI/ml and lixisenatide in the treatment intensifcation of diabetes mellitus type 2
by: S. К. Zyryanov, et al.
Published: (2019)

Effectiveness of Insulin Analogs Compared with Human Insulins in Pregnant Women with Diabetes Mellitus: Systematic Review and Meta-analysis
by: Leyna Leite Santos, et al.

Adherence to treatment for diabetes mellitus: validation of instruments for oral antidiabetics and insulin
by: Lilian Cristiane Gomes-Villas Boas, et al.
Published: (2014)

Expression of the Biologically Active Insulin Analog SCI-57 in Nicotiana Benthamiana
by: Adriana Muñoz-Talavera, et al.
Published: (2019)

Structural principles of insulin formulation and analog design: A century of innovation
by: Mark A. Jarosinski, et al.
Published: (2021)

Concept for a Unidirectional Release Mucoadhesive Buccal Tablet for Oral Delivery of Antidiabetic Peptide Drugs Such as Insulin, Glucagon-like Peptide 1 (GLP-1), and their Analogs
by: Anubhav Pratap-Singh, et al.
Published: (2023)

Premixed nitrous oxide and oxygen: A review
by: J. F. Coetzee
Published: (1973)

Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes
by: Qiong Luo, et al.
Published: (2022)

Cost-effectiveness of insulin analogs from the perspective of the Brazilian public health system
by: Maurílio de Souza Cazarim, et al.
Published: (2017)

Radiopacity of Premixed calcium silicate-based endodontic sealers
by: Dželetović Bojan, et al.
Published: (2021)

Real-world community hospital hyperglycemia management in noncritically ill, type 2 diabetic patients: a comparison between basal-bolus insulin and correctional insulin
by: Caiyun J. Yang, et al.
Published: (2024)

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia
by: Sofie Broeng-Mikkelgaard, et al.
Published: (2023)

Continuous insulin therapy versus multiple insulin injections in the management of type 1 diabetes: a longitutinal study
by: Maria Estela Bellini Ribeiro, et al.
Published: (2016)

Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety
by: Andréia Cristina Conegero Sanches, et al.
Published: (2013)

Predictors of Insulin Resistance in Children versus Adolescents with Obesity
by: Yvette E. Lentferink, et al.
Published: (2017)

Isolation and identification of an isomeric sildenafil analogue as an adulterant in an instant coffee premix
by: Ahmad Yusri Mohd Yusop, et al.
Published: (2020)

Approved and Commercialized Antidiabetic Medicines (Excluding Insulin) in Seven European Countries-A Cross-Sectional Comparison
by: Ana-Maria Atănăsoie, et al.
Published: (2024)

Carbohydrate counting and insulin analogs to treat type 1 diabetes mellitus. How to improve metabolic control?
by: Amanda Maria Barradas Monteiro de Santana, et al.
Published: (2024)